CytoMed Therapeutics Limited

GDTC | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.91

-$0.07 (-7.14%)

At close: Sep 21, 2026, 3:59 PM ET

$0.86

-$0.05 (-5.49%)

After-hours: Sep 21, 2026, 4:34 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-7.14%

(1D)

Rating

Updated: Sep 5, 2026

18.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $10.82M

1D Range

0.81 0.97

52W Range

0.68 3.68

Valuation (TTM)

PE -2.97

PB 2.13

EV/EBITDA -2.33

Valuation (NTM)

Forward PE N/A

Forward PEG 0.19

Price Target N/A

Cash Flow

FCF Yield -45.8%

SBC Adj. FCF Yield -46.7%

SBC Impact -1.9%

Margins

Gross Margin -20.5%

Operating Margin -672.2%

FCF Margin -986.0%

Growth (CAGR)

Revenue 3Y | 5Y 20.8% | 61.0%

Dil EPS 3Y | 5Y 8.7% | 2.6%

FCF 3Y | 5Y -29.3% | -26.4%

Returns

ROA -60.7%

ROE -70.7%

ROIC -58.9%

Financial Health

Net Cash

S$1.69M ($1.31M)

Current Ratio 5.17

Interest Coverage -209.99

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunother...

Sector Healthcare

Industry Biotechnology

Employees 42

IPO Date Apr 13, 2023

Website w2.cytomed.sg

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.